These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31586542)

  • 1. Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields.
    Gorman J; Mason RD; Nettey L; Cavett N; Chuang GY; Peng D; Tsybovsky Y; Verardi R; Nguyen R; Ambrozak D; Biris K; LaBranche CC; Ramesh A; Schramm CA; Zhou J; Bailer RT; Kepler TB; Montefiori DC; Shapiro L; Douek DC; Mascola JR; Roederer M; Kwong PD
    Immunity; 2019 Oct; 51(4):724-734.e4. PubMed ID: 31586542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.
    Hu G; Liu J; Roux KH; Taylor KA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.
    Zhou T; Zheng A; Baxa U; Chuang GY; Georgiev IS; Kong R; O'Dell S; Shahzad-Ul-Hussan S; Shen CH; Tsybovsky Y; Bailer RT; Gift SK; Louder MK; McKee K; Rawi R; Stevenson CH; Stewart-Jones GBE; Taft JD; Waltari E; Yang Y; Zhang B; Shivatare SS; Shivatare VS; Lee CD; Wu CY; ; Mullikin JC; Bewley CA; Burton DR; Polonis VR; Shapiro L; Wong CH; Mascola JR; Kwong PD; Wu X
    Immunity; 2018 Mar; 48(3):500-513.e6. PubMed ID: 29548671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.
    Wibmer CK; Gorman J; Anthony CS; Mkhize NN; Druz A; York T; Schmidt SD; Labuschagne P; Louder MK; Bailer RT; Abdool Karim SS; Mascola JR; Williamson C; Moore PL; Kwong PD; Morris L
    J Virol; 2016 Nov; 90(22):10220-10235. PubMed ID: 27581986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to the HIV-1 envelope high mannose patch.
    Daniels CN; Saunders KO
    Adv Immunol; 2019; 143():11-73. PubMed ID: 31607367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian Immunodeficiency Virus SIVmac239, but Not SIVmac316, Binds and Utilizes Human CD4 More Efficiently than Rhesus CD4.
    Fellinger CH; Gardner MR; Bailey CC; Farzan M
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.
    Pejchal R; Doores KJ; Walker LM; Khayat R; Huang PS; Wang SK; Stanfield RL; Julien JP; Ramos A; Crispin M; Depetris R; Katpally U; Marozsan A; Cupo A; Maloveste S; Liu Y; McBride R; Ito Y; Sanders RW; Ogohara C; Paulson JC; Feizi T; Scanlan CN; Wong CH; Moore JP; Olson WC; Ward AB; Poignard P; Schief WR; Burton DR; Wilson IA
    Science; 2011 Nov; 334(6059):1097-103. PubMed ID: 21998254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
    Yang Z; Dam KA; Gershoni JM; Zolla-Pazner S; Bjorkman PJ
    J Virol; 2022 Dec; 96(24):e0108222. PubMed ID: 36448805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
    Kilgore KM; Murphy MK; Burton SL; Wetzel KS; Smith SA; Xiao P; Reddy S; Francella N; Sodora DL; Silvestri G; Cole KS; Villinger F; Robinson JE; Pulendran B; Hunter E; Collman RG; Amara RR; Derdeyn CA
    J Virol; 2015 Aug; 89(16):8130-51. PubMed ID: 26018167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational Heterogeneity of the HIV Envelope Glycan Shield.
    Yang M; Huang J; Simon R; Wang LX; MacKerell AD
    Sci Rep; 2017 Jun; 7(1):4435. PubMed ID: 28667249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
    Burns DP; Collignon C; Desrosiers RC
    J Virol; 1993 Jul; 67(7):4104-13. PubMed ID: 8510218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.
    Kong L; Lee JH; Doores KJ; Murin CD; Julien JP; McBride R; Liu Y; Marozsan A; Cupo A; Klasse PJ; Hoffenberg S; Caulfield M; King CR; Hua Y; Le KM; Khayat R; Deller MC; Clayton T; Tien H; Feizi T; Sanders RW; Paulson JC; Moore JP; Stanfield RL; Burton DR; Ward AB; Wilson IA
    Nat Struct Mol Biol; 2013 Jul; 20(7):796-803. PubMed ID: 23708606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography.
    White TA; Bartesaghi A; Borgnia MJ; de la Cruz MJ; Nandwani R; Hoxie JA; Bess JW; Lifson JD; Milne JL; Subramaniam S
    J Virol; 2011 Dec; 85(23):12114-23. PubMed ID: 21937655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation.
    Zhang Y; Niu Y; Tian J; Liu X; Yao X; Liu H
    Chem Biol Drug Des; 2017 Dec; 90(6):1237-1246. PubMed ID: 28632942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
    Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
    J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.
    Zhao F; Berndsen ZT; Pedreño-Lopez N; Burns A; Allen JD; Barman S; Lee WH; Chakraborty S; Gnanakaran S; Sewall LM; Ozorowski G; Limbo O; Song G; Yong P; Callaghan S; Coppola J; Weisgrau KL; Lifson JD; Nedellec R; Voigt TB; Laurino F; Louw J; Rosen BC; Ricciardi M; Crispin M; Desrosiers RC; Rakasz EG; Watkins DI; Andrabi R; Ward AB; Burton DR; Sok D
    Nat Commun; 2022 Sep; 13(1):5236. PubMed ID: 36068229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope.
    Barnes CO; Gristick HB; Freund NT; Escolano A; Lyubimov AY; Hartweger H; West AP; Cohen AE; Nussenzweig MC; Bjorkman PJ
    Nat Commun; 2018 Mar; 9(1):1251. PubMed ID: 29593217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.